Related Experiment Videos
Treatment of gliomas in adults
1Department of Neurosurgery, Kumamoto University Medical School, Japan.
Abstract:
Gliomas are the most common tumors in the brain and are almost always malignant in adults. The most malignant and most common glioma is glioblastoma multiforme. Median survival of patients with glioblastoma is less than 20 months following treatment. This poor prognosis reflects the limited efficacy of the currently available treatment modalities. Therefore, many attempts have been made to improve the treatment of this lethal disease. This paper reviews the progress that has been made recently in the treatment of malignant glioma with a focus on studies reported during the last year.
Insights
Glioblastoma multiforme, a deadly brain cancer, has limited treatment options and poor patient survival. Recent research focuses on improving therapies for malignant gliomas, offering hope for better outcomes.
Area of Science:
- Neuro-oncology
- Cancer research
- Clinical neurology
Background:
- Gliomas are primary brain tumors, frequently malignant in adults.
- Glioblastoma multiforme represents the most aggressive and prevalent glioma type.
- Current glioblastoma treatments offer limited efficacy, resulting in a median survival under 20 months.
Purpose of the Study:
- To review recent advancements in treating malignant gliomas.
- To highlight therapeutic progress reported within the last year.
- To address the urgent need for improved glioblastoma treatment strategies.
Main Methods:
- Literature review of recent studies on malignant glioma treatment.
- Focus on research published in the past year.
- Synthesis of findings on novel and established therapeutic approaches.
Main Results:
- Identification of emerging treatment strategies for malignant gliomas.
- Assessment of the latest clinical trial outcomes and preclinical findings.
- Analysis of progress in enhancing glioblastoma patient survival and quality of life.
Conclusions:
- Recent research shows promise in improving malignant glioma treatment.
- Continued investigation is crucial to overcome the challenges of glioblastoma.
- Novel therapeutic approaches may lead to better patient prognoses in the future.